Cargando…
PMON49 Checkpoint Inhibitor Induced Hypophysitis with Growth Hormone Deficiency and Implications for the Treatment of ACTH Deficiency
BACKGROUND/PURPOSE: Hypophysitis is a known complication of immune checkpoint inhibitor (ICI) therapies used in the treatment of malignant cancers. In general, central adrenal insufficiency (AI) and hypothyroidism are the most recognized deficiencies following a diagnosis of ICI induced hypophysitis...
Autores principales: | DeCherney, Stephen, Favoreto, Natalia, Fiacco, Nicholas, Ishizawar, Rumey, Saxena-Beem, Shruti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625555/ http://dx.doi.org/10.1210/jendso/bvac150.1151 |
Ejemplares similares
-
PMON100 IgG4 hypophysitis with granulomatous histopathology
por: Gultekin, Sakir, et al.
Publicado: (2022) -
PMON64 Economic Burden of Growth Hormone Deficiency in a US Adult Population
por: Smith, Alden, et al.
Publicado: (2022) -
PMON81 A Case of Hypophysitis Associated With SARS-CoV2 Vaccination
por: Ankireddypalli, Anvitha, et al.
Publicado: (2022) -
PMON82 SARS-CoV-2 Associated Hypophysitis and Central Diabetes Insipidus
por: Engel, Ashley, et al.
Publicado: (2022) -
PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH
por: Wilson, Sarah, et al.
Publicado: (2022)